Clinical Associate Professor
The Ohio State University College of Pharmacy
Columbus, Ohio
VP Business Development
Managing Partner, Safe Medication Management
East Greenwich, Rhode Island
Often patients want to know whether subcutaneous administration is a route that is appropriate for them when they are receiving chronic immunoglobulin (Ig) therapy.
Subcutaneous (SC) administration of Ig is an alternative to intravenous administration of Ig that may offer significant